Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
GMS Inc. price target raised to $58 from $51 at RBC Capital » 08:23
12/09/22
12/09
08:23
12/09/22
08:23
GMS

GMS Inc.

$55.00 /

+5.635 (+11.42%)

RBC Capital analyst Mike…

RBC Capital analyst Mike Dahl raised the firm's price target on GMS Inc. to $58 from $51 but keeps a Sector Perform rating on the shares after its Q2 earnings beat. The company's continued pricing and margin upside delays and potentially limits expected earnings declines, though he still sees the headwinds from its residential business outweighing commercial, the analyst tells investors in a research note. Dahl adds however that at less than 6-times his expected 2023 EBITDA, this risk seems "adequately priced in".

ShowHide Related Items >><<
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

12/09/22 Loop Capital
GMS Inc. downgraded to Hold at Loop Capital on valuation
12/09/22 Baird
GMS Inc. price target raised to $67 from $56 at Baird
12/09/22 Loop Capital
GMS Inc. downgraded to Hold from Buy at Loop Capital
09/07/22 Truist
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

Downgrade
GMS Inc. downgraded to Hold at Loop Capital on valuation » 07:21
12/09/22
12/09
07:21
12/09/22
07:21
GMS

GMS Inc.

$55.00 /

+5.635 (+11.42%)

Loop Capital analyst…

Loop Capital analyst Jeffrey Stevenson downgraded GMS Inc. to Hold from Buy with a price target of $60, up from $52. The company reported a "strong beat" with its Q2 results thanks to better-than-expected wallboard business with double-digit organic volume increase and 30% pricing growth, the analyst tells investors in a research note. Stevenson adds however that while GMS has outperformed given its balanced end market exposure, consistent earnings performance and strong free cash flow generation, the stock's risk-reward is now "accurately reflected" in valuation, particularly given the uncertainties surrounding residential cycle concerns and wallboard pricing moving forward.

ShowHide Related Items >><<
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

12/09/22 Baird
GMS Inc. price target raised to $67 from $56 at Baird
12/09/22 Loop Capital
GMS Inc. downgraded to Hold from Buy at Loop Capital
09/07/22 Truist
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction
09/07/22 Truist
GMS Inc. downgraded to Hold from Buy at Truist
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

Recommendations
GMS Inc. price target raised to $67 from $56 at Baird » 07:05
12/09/22
12/09
07:05
12/09/22
07:05
GMS

GMS Inc.

$55.00 /

+5.635 (+11.42%)

Baird analyst David…

Baird analyst David Manthey raised the firm's price target on GMS Inc. to $67 from $56 and keeps an Outperform rating on the shares. The analyst said they reported a strong quarter as wallboard volumes/pricing were unexpectedly resilient. He said he fully anticipates a softening which leads him to model earnings down significantly next year, but even on recessionary estimates, the company trades near an all-time low multiple, creating an attractive entry point.

ShowHide Related Items >><<
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

12/09/22 Loop Capital
GMS Inc. downgraded to Hold from Buy at Loop Capital
09/07/22 Truist
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction
09/07/22 Truist
GMS Inc. downgraded to Hold from Buy at Truist
06/24/22 Truist
GMS Inc. price target lowered to $50 from $65 at Truist
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

Downgrade
GMS Inc. downgraded to Hold from Buy at Loop Capital » 06:10
12/09/22
12/09
06:10
12/09/22
06:10
GMS

GMS Inc.

$55.00 /

+5.635 (+11.42%)

Loop Capital analyst…

Loop Capital analyst Jeffrey Stevenson downgraded GMS Inc. to Hold from Buy with a $60 price target.

ShowHide Related Items >><<
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

09/07/22 Truist
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction
09/07/22 Truist
GMS Inc. downgraded to Hold from Buy at Truist
06/24/22 Truist
GMS Inc. price target lowered to $50 from $65 at Truist
06/24/22 Baird
GMS Inc. price target lowered to $55 from $68 at Baird
GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

GMS GMS Inc.
$55.00 /

+5.635 (+11.42%)

Hot Stocks
GMS Inc. rises 8.6% » 10:00
12/08/22
12/08
10:00
12/08/22
10:00
GMS

GMS Inc.

$53.63 /

+4.27 (+8.65%)

GMS Inc. is up 8.6%, or…

GMS Inc. is up 8.6%, or $4.25 to $53.63.

ShowHide Related Items >><<
GMS GMS Inc.
$53.63 /

+4.27 (+8.65%)

GMS GMS Inc.
$53.63 /

+4.27 (+8.65%)

09/07/22 Truist
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction
09/07/22 Truist
GMS Inc. downgraded to Hold from Buy at Truist
06/24/22 Truist
GMS Inc. price target lowered to $50 from $65 at Truist
06/24/22 Baird
GMS Inc. price target lowered to $55 from $68 at Baird
GMS GMS Inc.
$53.63 /

+4.27 (+8.65%)

GMS GMS Inc.
$53.63 /

+4.27 (+8.65%)

Hot Stocks
GMS Inc. rises 8.5% » 09:47
12/08/22
12/08
09:47
12/08/22
09:47
GMS

GMS Inc.

$53.96 /

+4.6 (+9.32%)

GMS Inc. is up 8.5%, or…

GMS Inc. is up 8.5%, or $4.21 to $53.59.

ShowHide Related Items >><<
GMS GMS Inc.
$53.96 /

+4.6 (+9.32%)

GMS GMS Inc.
$53.96 /

+4.6 (+9.32%)

09/07/22 Truist
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction
09/07/22 Truist
GMS Inc. downgraded to Hold from Buy at Truist
06/24/22 Truist
GMS Inc. price target lowered to $50 from $65 at Truist
06/24/22 Baird
GMS Inc. price target lowered to $55 from $68 at Baird
GMS GMS Inc.
$53.96 /

+4.6 (+9.32%)

GMS GMS Inc.
$53.96 /

+4.6 (+9.32%)

Earnings
GMS Inc. reports Q2 adjusted EPS $2.79, consensus $2.34 » 06:02
12/08/22
12/08
06:02
12/08/22
06:02
GMS

GMS Inc.

$49.34 /

+1.52 (+3.18%)

Reports Q2 revenue…

Reports Q2 revenue $1.43B, consensus $1.36B. "A significant backlog of homes under construction, continued strength in multi-family, and improving levels of commercial activity helped drive exceptional results for our Q2," said CEO John Turner, Jr. "As a result, with favorable pricing across our product categories, positive volume growth in Wallboard, Ceilings and Complementary Products and the benefit of our AMES acquisition, our team achieved another quarter of record levels of net sales, net income and Adjusted EBITDA and generated significant levels of cash flow. With significant scale, a balanced mix of commercial and residential customers and a wide breadth of product offerings, we are confident in our ability to adjust as needed to meet demand in all of our end markets and believe we are well-positioned ahead of the developing slowdown in residential single-family construction. We remain focused on the execution of our strategic priorities to expand share in our core products, grow Complementary Product offerings, expand our platform, and leverage our scale to achieve improved productivity and profitability through the use of technology and shared best practices."

ShowHide Related Items >><<
GMS GMS Inc.
$49.34 /

+1.52 (+3.18%)

GMS GMS Inc.
$49.34 /

+1.52 (+3.18%)

09/07/22 Truist
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction
09/07/22 Truist
GMS Inc. downgraded to Hold from Buy at Truist
06/24/22 Truist
GMS Inc. price target lowered to $50 from $65 at Truist
06/24/22 Baird
GMS Inc. price target lowered to $55 from $68 at Baird
GMS GMS Inc.
$49.34 /

+1.52 (+3.18%)

GMS GMS Inc.
$49.34 /

+1.52 (+3.18%)

Over a quarter ago
On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:01
09/07/22
09/07
10:01
09/07/22
10:01
NFLX

Netflix

$221.92 /

+3.56 (+1.63%)

, PINS

Pinterest

$23.45 /

+1.37 (+6.20%)

, RHP

Ryman Hospitality

$82.39 /

+1.85 (+2.30%)

, BILI

Bilibili

$22.70 /

+0.19 (+0.84%)

, NVS

Novartis

$80.23 /

+0.46 (+0.58%)

, EA

Electronic Arts

$124.04 /

-0.74 (-0.59%)

, NTES

NetEase

$86.73 /

-0.055 (-0.06%)

, PATH

UiPath

$13.00 /

-2.58 (-16.56%)

, GMS

GMS Inc.

$44.68 /

-0.95 (-2.08%)

, VBTX

Veritex

$27.70 /

-1.3 (-4.48%)

, TDOC

Teladoc

$29.47 /

+0.42 (+1.45%)

, DOCS

Doximity

$32.61 /

+0.48 (+1.49%)

, CHPT

ChargePoint

$15.68 /

+0.92 (+6.24%)

, WBX

Wallbox

$8.62 /

+0.42 (+5.12%)

, MEDP

Medpace

$146.39 /

+1.19 (+0.82%)

, ICLR

Icon

$212.79 /

+4.25 (+2.04%)

, GDRX

GoodRx

$5.86 /

-0.04 (-0.68%)

Institutional investors…

ShowHide Related Items >><<
WBX Wallbox
$8.62 /

+0.42 (+5.12%)

VBTX Veritex
$27.70 /

-1.3 (-4.48%)

TDOC Teladoc
$29.47 /

+0.42 (+1.45%)

RHP Ryman Hospitality
$82.39 /

+1.85 (+2.30%)

PINS Pinterest
$23.45 /

+1.37 (+6.20%)

PATH UiPath
$13.00 /

-2.58 (-16.56%)

NVS Novartis
$80.23 /

+0.46 (+0.58%)

NTES NetEase
$86.73 /

-0.055 (-0.06%)

NFLX Netflix
$221.92 /

+3.56 (+1.63%)

MEDP Medpace
$146.39 /

+1.19 (+0.82%)

GMS GMS Inc.
$44.68 /

-0.95 (-2.08%)

GDRX GoodRx
$5.86 /

-0.04 (-0.68%)

EA Electronic Arts
$124.04 /

-0.74 (-0.59%)

DOCS Doximity
$32.61 /

+0.48 (+1.49%)

CHPT ChargePoint
$15.68 /

+0.92 (+6.24%)

BILI Bilibili
$22.70 /

+0.19 (+0.84%)

NFLX Netflix
$221.92 /

+3.56 (+1.63%)

09/07/22 Jefferies
Netflix price target lowered to $230 from $243 at Jefferies
09/07/22 Macquarie
Macquarie upgrades Netflix to Neutral on longer term upside from ads
09/07/22 Macquarie
Netflix upgraded to Neutral from Underperform at Macquarie
08/31/22 Citi
Snap downgraded to Neutral from Buy at Citi
PINS Pinterest
$23.45 /

+1.37 (+6.20%)

09/07/22 Wolfe Research
Pinterest upgraded to Outperform from Peer Perform at Wolfe Research
08/02/22 Evercore ISI
Pinterest price target raised to $28 from $24 at Evercore ISI
08/02/22 Baird
Pinterest results for Q2 better than feared, says Baird
08/02/22 Citi
Pinterest price target raised to $25 from $24 at Citi
RHP Ryman Hospitality
$82.39 /

+1.85 (+2.30%)

09/07/22 Truist
Ryman Hospitality upgraded to Buy at Truist on corporate group exposure
09/07/22 Truist
Ryman Hospitality upgraded to Buy from Hold at Truist
08/03/22 Deutsche Bank
Ryman Hospitality price target raised to $121 from $116 at Deutsche Bank
06/23/22 Citi
Citi adds AutoZone, Thermo Fisher, Ionis to 'Focus List'
BILI Bilibili
$22.70 /

+0.19 (+0.84%)

09/07/22 JPMorgan
Bilibili assumed at Overweight from Neutral at JPMorgan
08/01/22 Goldman Sachs
Bilibili received one China game approval for August, says Goldman Sachs
06/13/22 JPMorgan
Bilibili price target raised to $25 from $19 at JPMorgan
06/10/22 Citi
Bilibili price target lowered to $45 from $46 at Citi
NVS Novartis
$80.23 /

+0.46 (+0.58%)

09/07/22 Kepler Cheuvreux
Novartis upgraded to Buy from Hold at Kepler Cheuvreux
08/05/22 Truist
Global Blood could complement any oncology franchise, says Truist
08/04/22 Truist
Truist sees Novartis, Vertex as logical suitors for Global Blood
07/20/22 JPMorgan
Novartis price target raised to CHF 81 from CHF 80 at JPMorgan
EA Electronic Arts
$124.04 /

-0.74 (-0.59%)

09/07/22 MKM Partners
MKM Partners cuts Electronic Arts to Neutral on further margin contraction
09/07/22 MKM Partners
Electronic Arts downgraded to Neutral from Buy at MKM Partners
08/29/22 Citi
Amazon deal for Electronic Arts would bring regulatory risks, says Citi
08/26/22 Benchmark
EA could be valued at $188 per share in competitive process, says Benchmark
NTES NetEase
$86.73 /

-0.055 (-0.06%)

09/07/22 JPMorgan
NetEase assumed with Neutral from Overweight at JPMorgan
08/19/22 Citi
NetEase price target raised to $140 from $132 at Citi
07/05/22 Macquarie
China online gaming re-ratings 'about to begin,' says Macquarie
PATH UiPath
$13.00 /

-2.58 (-16.56%)

09/07/22 Canaccord
UiPath downgraded to Hold at Canaccord after 'largely disappointing' Q2 report
09/07/22 Canaccord
UiPath downgraded to Hold from Buy at Canaccord
09/07/22 Truist
UiPath price target lowered to $25 from $45 at Truist
09/07/22 BMO Capital
UiPath price target lowered to $15 from $21 at BMO Capital
GMS GMS Inc.
$44.68 /

-0.95 (-2.08%)

09/07/22 Truist
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction
09/07/22 Truist
GMS Inc. downgraded to Hold from Buy at Truist
06/24/22 Truist
GMS Inc. price target lowered to $50 from $65 at Truist
06/24/22 Baird
GMS Inc. price target lowered to $55 from $68 at Baird
VBTX Veritex
$27.70 /

-1.3 (-4.48%)

09/07/22 Stephens
Stephens downgrades Veritex, sees bank in 'difficult position' after deal nixed
09/07/22 Stephens
Veritex downgraded to Equal Weight from Overweight at Stephens
07/07/22 Raymond James
Veritex downgraded to Outperform from Strong Buy at Raymond James
07/07/22 Raymond James
Veritex downgraded to Outperform from Strong Buy at Raymond James
TDOC Teladoc
$29.47 /

+0.42 (+1.45%)

09/07/22 Truist
Teladoc initiated with a Hold at Truist
09/02/22 Piper Sandler
Teladoc long-term thesis remains intact, says Piper Sandler
08/17/22 Guggenheim
Guggenheim cuts Teladoc to Sell with growth remaining pressured
08/17/22 Guggenheim
Teladoc downgraded to Sell from Neutral at Guggenheim
DOCS Doximity
$32.61 /

+0.48 (+1.49%)

09/07/22 Truist
Doximity initiated with a Hold at Truist
08/23/22 Canaccord
Doximity estimates updated to within guidance range at Canaccord
08/05/22 Canaccord
Doximity price target lowered to $42 from $47 at Canaccord
08/05/22 BofA
Doximity downgraded to Underperform on customer pullback at BofA
CHPT ChargePoint
$15.68 /

+0.92 (+6.24%)

09/07/22 Credit Suisse
ChargePoint initiated with an Outperform at Credit Suisse
08/31/22 Oppenheimer
ChargePoint results strong despite supply headwinds, says Oppenheimer
08/31/22 JPMorgan
ChargePoint leadership remains underappreciated, says JPMorgan
08/23/22 JPMorgan
ChargePoint price target raised to $20 from $18 at JPMorgan
WBX Wallbox
$8.62 /

+0.42 (+5.12%)

09/07/22 Credit Suisse
Wallbox initiated with an Outperform at Credit Suisse
08/11/22 Stifel
Wallbox price target lowered to $20 from $24 at Stifel
08/04/22 Barclays
Wallbox initiated with an Overweight at Barclays
07/13/22 Canaccord
Wallbox initiated with a Buy at Canaccord
MEDP Medpace
$146.39 /

+1.19 (+0.82%)

09/07/22 UBS
Medpace initiated with a Sell at UBS
05/23/22 Guggenheim
Medpace initiated with Neutral on pre-revenue focus at Guggenheim
05/23/22 Guggenheim
Medpace initiated with a Neutral at Guggenheim
03/17/22 Baird
Medpace price target raised to $175 from $160 at Baird
ICLR Icon
$212.79 /

+4.25 (+2.04%)

09/07/22 UBS
Icon initiated with a Buy at UBS
08/24/22 Credit Suisse
Icon initiated with a Neutral at Credit Suisse
07/29/22 Deutsche Bank
Icon price target raised to $295 from $285 at Deutsche Bank
07/14/22 Deutsche Bank
Icon price target lowered to $285 from $310 at Deutsche Bank
GDRX GoodRx
$5.86 /

-0.04 (-0.68%)

09/07/22 Truist
GoodRx initiated with a Hold at Truist
08/11/22 DA Davidson
GoodRx initiated with a Neutral at DA Davidson
08/09/22 Goldman Sachs
Goldman Sachs raises GoodRx price target to $10 amid grocer issue resolution
08/09/22 RBC Capital
GoodRx price target raised to $11 from $6.50 at RBC Capital
VBTX Veritex
$27.70 /

-1.3 (-4.48%)

TDOC Teladoc
$29.47 /

+0.42 (+1.45%)

RHP Ryman Hospitality
$82.39 /

+1.85 (+2.30%)

PINS Pinterest
$23.45 /

+1.37 (+6.20%)

PATH UiPath
$13.00 /

-2.58 (-16.56%)

NVS Novartis
$80.23 /

+0.46 (+0.58%)

NTES NetEase
$86.73 /

-0.055 (-0.06%)

NFLX Netflix
$221.92 /

+3.56 (+1.63%)

MEDP Medpace
$146.39 /

+1.19 (+0.82%)

ICLR Icon
$212.79 /

+4.25 (+2.04%)

GMS GMS Inc.
$44.68 /

-0.95 (-2.08%)

GDRX GoodRx
$5.86 /

-0.04 (-0.68%)

EA Electronic Arts
$124.04 /

-0.74 (-0.59%)

DOCS Doximity
$32.61 /

+0.48 (+1.49%)

CHPT ChargePoint
$15.68 /

+0.92 (+6.24%)

BILI Bilibili
$22.70 /

+0.19 (+0.84%)

  • 04
    Mar
TDOC Teladoc
$29.47 /

+0.42 (+1.45%)

PINS Pinterest
$23.45 /

+1.37 (+6.20%)

NVS Novartis
$80.23 /

+0.46 (+0.58%)

NTES NetEase
$86.73 /

-0.055 (-0.06%)

NFLX Netflix
$221.92 /

+3.56 (+1.63%)

EA Electronic Arts
$124.04 /

-0.74 (-0.59%)

BILI Bilibili
$22.70 /

+0.19 (+0.84%)

WBX Wallbox
$8.62 /

+0.42 (+5.12%)

TDOC Teladoc
$29.47 /

+0.42 (+1.45%)

PINS Pinterest
$23.45 /

+1.37 (+6.20%)

PATH UiPath
$13.00 /

-2.58 (-16.56%)

NVS Novartis
$80.23 /

+0.46 (+0.58%)

NTES NetEase
$86.73 /

-0.055 (-0.06%)

NFLX Netflix
$221.92 /

+3.56 (+1.63%)

ICLR Icon
$212.79 /

+4.25 (+2.04%)

GDRX GoodRx
$5.86 /

-0.04 (-0.68%)

EA Electronic Arts
$124.04 /

-0.74 (-0.59%)

DOCS Doximity
$32.61 /

+0.48 (+1.49%)

CHPT ChargePoint
$15.68 /

+0.92 (+6.24%)

BILI Bilibili
$22.70 /

+0.19 (+0.84%)

TDOC Teladoc
$29.47 /

+0.42 (+1.45%)

PINS Pinterest
$23.45 /

+1.37 (+6.20%)

PATH UiPath
$13.00 /

-2.58 (-16.56%)

NVS Novartis
$80.23 /

+0.46 (+0.58%)

NTES NetEase
$86.73 /

-0.055 (-0.06%)

NFLX Netflix
$221.92 /

+3.56 (+1.63%)

GDRX GoodRx
$5.86 /

-0.04 (-0.68%)

EA Electronic Arts
$124.04 /

-0.74 (-0.59%)

DOCS Doximity
$32.61 /

+0.48 (+1.49%)

CHPT ChargePoint
$15.68 /

+0.92 (+6.24%)

BILI Bilibili
$22.70 /

+0.19 (+0.84%)

Downgrade
Truist cuts GMS Inc. to Hold on impact from downturn in residential construction » 07:20
09/07/22
09/07
07:20
09/07/22
07:20
GMS

GMS Inc.

$45.63 /

-0.35 (-0.76%)

Truist analyst Keith…

Truist analyst Keith Hughes downgraded GMS Inc. to Hold from Buy with a price target of $46, down from $50. The analyst warns that the residential construction downturn will put pressure on wallboard prices in 2023, which will compress margins at both the manufacturer and the distributor level. Hughes adds that while roughly half of GMS business is commercial and will help support numbers, but investor emphasis on wallboard prices could prevent this upside.

ShowHide Related Items >><<
GMS GMS Inc.
$45.63 /

-0.35 (-0.76%)

GMS GMS Inc.
$45.63 /

-0.35 (-0.76%)

09/07/22 Truist
GMS Inc. downgraded to Hold from Buy at Truist
06/24/22 Truist
GMS Inc. price target lowered to $50 from $65 at Truist
06/24/22 Baird
GMS Inc. price target lowered to $55 from $68 at Baird
06/22/22 RBC Capital
RBC Capital cuts GMS Inc. to Sector Perform on eroding pricing and margins
GMS GMS Inc.
$45.63 /

-0.35 (-0.76%)

Downgrade
GMS Inc. downgraded to Hold from Buy at Truist » 06:31
09/07/22
09/07
06:31
09/07/22
06:31
GMS

GMS Inc.

$45.63 /

-0.35 (-0.76%)

Truist analyst Keith…

Truist analyst Keith Hughes downgraded GMS Inc. to Hold from Buy with a price target of $46, down from $50.

ShowHide Related Items >><<
GMS GMS Inc.
$45.63 /

-0.35 (-0.76%)

GMS GMS Inc.
$45.63 /

-0.35 (-0.76%)

06/24/22 Truist
GMS Inc. price target lowered to $50 from $65 at Truist
06/24/22 Baird
GMS Inc. price target lowered to $55 from $68 at Baird
06/22/22 RBC Capital
RBC Capital cuts GMS Inc. to Sector Perform on eroding pricing and margins
06/22/22 RBC Capital
GMS Inc. downgraded to Sector Perform from Outperform at RBC Capital
GMS GMS Inc.
$45.63 /

-0.35 (-0.76%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.